Abstract
Neurocognitive functioning is an integral phenotype of 22q11.2 deletion syndrome relating to severity of psychopathology and outcomes. A neurocognitive battery that could be administered remotely to assess multiple cognitive domains would be especially beneficial to research on rare genetic variants, where in-person assessment can be unavailable or burdensome. The current study compares in-person and remote assessments of the Penn computerised neurocognitive battery (CNB). Participants (mean age=17.82, SD=6.94years; 48% female) completed the CNB either in-person at a laboratory (n=222) or remotely (n=162). Results show that accuracy of CNB performance was equivalent across the two testing locations, while slight differences in speed were detected in 3 of the 11 tasks. These findings suggest that the CNB can be used in remote settings to assess multiple neurocognitive domains.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have